Striatal cholinergic interneurons and Parkinson's disease
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Giant, aspiny cholinergic interneurons (ChIs) have long been known to be key nodes in the striatal circuitry controlling goal‐directed actions and habits. In recent years, new experimental approaches, like optogenetics and monosynaptic rabies virus mapping, have expanded our understanding of how ChIs contribute to the striatal activity underlying action selection and the interplay of dopaminergic and cholinergic signaling. These approaches also have begun to reveal how ChI function is distorted in disease states affecting the basal ganglia, like Parkinson's disease (PD). This review gives a brief overview of our current understanding of the functional role played by ChIs in striatal physiology and how this changes in PD. The translational implications of these discoveries, as well as the gaps that remain to be bridged, are discussed as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dichotomous dopaminergic control of striatal synaptic plasticity
Shen, W., Flajolet, M., Greengard, P., & Surmeier, D. J. (2008) · Science · doi:10.1126/science.1160575 · Cited by 1,190
Self-citationLoss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., & Calabresi, P. (2003) · Nature Neuroscience · doi:10.1038/nn1040 · Cited by 821 · cited 2×
“Several lines of evidence suggest that aberrant D1R-dependent potentiation of dSPNs glutamatergic synapses is a central feature of the LIDs pathophysiology (Picconi et al., 2003; Jenner, 2008; Feyder et al., 2011).”
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
Kreitzer, A. C., & Malenka, R. C. (2007) · Nature · doi:10.1038/nature05506 · Cited by 735 · cited 2×
“A number of studies using MLS have failed to find LTD in dSPNs (Kreitzer & Malenka, 2007; Shen et al., 2008; Nazzaro et al., 2012).”
Nicotine amplifies reward-related dopamine signals in striatum
Rice, M. E., & Cragg, S. J. (2004) · Nature Neuroscience · doi:10.1038/nn1244 · Cited by 594 · cited 1×
“…subsequent DA release during a burst of action potentials; conversely, desensitizing (by applying nicotine at concentrations achieved by smoking) or antagonizing nAChRs increased DA release during burst spiking (Zhou et al., 2001; Rice & Cragg, 2004; Zhang & Sulzer, 2004; Exley & Cragg, 2008).”
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum
Zhou, F.-M., Liang, Y., & Dani, J. A. (2001) · Nature Neuroscience · doi:10.1038/nn769 · Cited by 585 · cited 2×
“In contrast with the earlier release studies, work examining phasic DA release using cyclic voltammetry suggested that tonic nAChRs signaling increased the initial release probability of DA following an action potential but limited subsequent DA release during a burst of action potentials; conversely, desensitizing (b…”
Le Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385
Frequency-dependent modulation of dopamine release by nicotine
Zhang, H., & Sulzer, D. (2004) · Nature Neuroscience · doi:10.1038/nn1243 · Cited by 361 · cited 1×
“…subsequent DA release during a burst of action potentials; conversely, desensitizing (by applying nicotine at concentrations achieved by smoking) or antagonizing nAChRs increased DA release during burst spiking (Zhou et al., 2001; Rice & Cragg, 2004; Zhang & Sulzer, 2004; Exley & Cragg, 2008).”
Grady, S., Marks, M. J., Wonnacott, S., & Collins, A. C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08322.x · Cited by 350
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252 · cited 1×
“Indeed, dopaminergic neurons express a4 and b2 subunits at high levels, and lower levels of a5-7, and b3 subunits (Clarke & Pert, 1985; Le Novere et al., 1996; Sharples et al., 2000; Jones et al., 2001; Quik et al., 2003; Grady et al., 2007).”
Chuhma, N., Mingote, S., Moore, H., & Rayport, S. (2014) · Neuron · doi:10.1016/j.neuron.2013.12.027 · Cited by 233 · cited 1×
“This inference is consistent with studies examining the effects of activity evoked DA release on ChIs (Ding et al., 2010; Chuhma et al., 2014).”
Cited by
Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches
Bohnen, N. I., Yarnall, A. J., Weil, R. S., Moro, E., Moehle, M. S., Borghammer, P., Bedard, M.-A., & Albin, R. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00377-x · Cited by 293
Kramer, P. F., Brill-Weil, S. G., Cummins, A. C., Zhang, R., Camacho-Hernandez, G. A., Newman, A. H., Eldridge, M. A. G., Averbeck, B. B., & Khaliq, Z. M. (2022) · Neuron · doi:10.1016/j.neuron.2022.07.011 · Cited by 104
Khan, S. S., Jaimon, E., Lin, Y.-E., Nikoloff, J., Tonelli, F., Alessi, D. R., & Pfeffer, S. R. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402206121 · Cited by 61
Lin, Y.-E., Jaimon, E., Tonelli, F., & Pfeffer, S. R. (2025) · Life Science Alliance · doi:10.26508/lsa.202402922 · Cited by 16
“Among the most well-characterized striatal interneurons are the parvalbumin (PV) and cholinergic cell types (Tanimura et al, 2018; Gritton et al, 2019).”
Metadata
- Authors
- Tanimura, A., Pancani, T., Lim, S. A. O., Tubert, C., Melendez, A. E., Shen, W., & Surmeier, D. J.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2017-07-20
- Volume
- 47
- Issue
- 10
- Pages
- 1148-1158
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2724098740
- Cited by
- 93
- References
- 17
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Striatal cholinergic interneurons and Parkinson's disease. https://app.cochat.ai/papers/10.1111/ejn.13638
- The paper
- Tanimura, A., Pancani, T., Lim, S. A. O., Tubert, C., Melendez, A. E., Shen, W., & Surmeier, D. J. (2018). Striatal cholinergic interneurons and Parkinson's disease. European Journal of Neuroscience. https://doi.org/10.1111/ejn.13638
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.